A phase 1, open-label, randomized, single-dose, three-treatment, three period, six-sequence crossover study to evaluate the effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, a single tablet regimen in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2015
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 12 Dec 2015 New trial record